💊

Sutent

sunitinib

Guzy stromalne przewodu pokarmowego;rak nerki;guzy neuroendokrynne

✅ Upoważniony

✅

Brak aktywnych alertów

Ten lek nie jest objęty bieżącymi niedoborami, listami ostrzegawczymi ani wycofany z rynku.

Do czego to służy

Gastrointestinal stromal tumour (GIST) Sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. Metastatic renal cell carcinoma (MRCC) Sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults. Pancreatic neuroendocrine tumours (pNET) Sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. Experience with Sutent as first-line treatment is limited (see section 5.1).

⚠️ Bezpieczeństwo pacjenta

Oficjalna strona EMA

https://www.ema.europa.eu/en/medicines/human/EPAR/sutent